Article just released on MGC Pharma's ArtemiC:
https://thegreenfund.com/is-mgc-pharma-sitting-on-a-covid-19-cure
About a 5min read.
'Results from MGC Pharma's double-blind Phase II trial on COVID-19 patients in Israel are due in early August, so they could come any day now. When the results arrive, investors should be keeping a keen eye on whether ArtemiC can successfully minimize the body's immunological response to COVID-19, and to what extent'.
Ann: Phase II Clinical Trial on COVID-19 Patients Commenced, page-20
-
- There are more pages in this discussion • 17 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add RGT (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
34.0¢ |
Change
0.035(11.5%) |
Mkt cap ! $16.45M | |||
| Open | High | Low | Value | Volume |
| 30.0¢ | 34.0¢ | 30.0¢ | $1.873K | 5.613K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 43905 | 32.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 34.0¢ | 483 | 3 |
View Market Depth
| Last trade - 15.32pm 02/09/2024 (20 minute delay) ? |
| RGT (ASX) Chart |